Allarity Therapeutics Inc Sustainability Reports
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing personalized cancer treatments. The company utilizes its proprietary Drug Response Predictor (DRP) platform to identify patients most likely to benefit from its oncology therapeutics.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG012NXCZQ7
3 reports from 2020 to 2024
Company Profile
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing personalized cancer treatments. The company utilizes its proprietary Drug Response Predictor (DRP) platform to identify patients most likely to benefit from its oncology therapeutics.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
